Laurolactam-Based Transparent PA Resin Pellets from Canada
Primary pellets of laurolactam-isophthalic acid-bis(4-amino-3-methylcyclohexyl)methane copolymer for medical device molding. HTS 3908.90.2000 due to specific naming in polyamide subheadings with predominant monomer compliance. Biocompatible and sterilizable for healthcare uses.
Duty Rate — Canada → United States
10%
Rate breakdown
9903.03.0110%Except for products described in headings 9903.03.02–9903.03.11, articles the product of any country, as provided for in subdivision (aa) of U.S. note 2 to this subchapter
Import Tips
• Comply with FDA import requirements alongside CBP; provide biocompatibility test data; declare as primary form only - not compounded